Senfølger af COVID-19 – status og udfordringer
Anna Irene Vedel Sørensen(Statens Serum Institut), Tyra Grove Krause(Statens Serum Institut), Steffen Leth(Aarhus University Hospital), Anders Hviid(Statens Serum Institut), Anne Øvrehus(University of Southern Denmark), Hatice Tankişi(Aarhus University), Maléne Møller Jørgensen(Aalborg University Hospital), Karen Mølgaard Christiansen(University of Southern Denmark), Jane Agergaard(Aarhus University Hospital), Anders Koch(Statens Serum Institut), Sophie Gubbels(Statens Serum Institut), Henrik Ullum(Statens Serum Institut)
Unknown
April 1, 2023
Cited by 0
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
|The Lancet Respiratory Medicine|2014|648
Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles
|Nature Genetics|2022|396
Exosomal proteins as potential diagnostic markers in advanced non‐small cell lung carcinoma
|Journal of Extracellular Vesicles|2015|345
Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort
|International Journal of Epidemiology|2020|280